Passive immunotherapy for Parkinson's disease in 2025: Status and perspective.
Passive immunotherapy for Parkinson's disease in 2025: Status and perspective.
Where did the research take place?
The study site has not been established. Author addresses may differ from where the research occurred.
Barcelona, ES · Author affiliation
Institute of Biotechnology and Biomedicine (IBB) and Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, Bellaterra, Barcelona, Spain (González-Artero A, Bárcenas O, Pujols J, Ventura S).Location evidence
Sabadell, ES · Author affiliation
Parc Taulí University Hospital, Parc Taulí Research and Innovation Institute (I3PT-CERCA), Autonomous University of Barcelona, Sabadell, Spain (Ventura S).Location evidence
A plain-language reading has not been prepared for this paper yet.